- Service Name
Absci
- Industry
Biotechnology, Drug Discovery, Biologics, AI-driven Drug Development
- Main Value Proposition
Absci aims to create better biologics for patients faster by leveraging AI to uncover novel biology and streamline the drug discovery process.
- Description
Absci is a drug and target discovery company that utilizes deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. The company focuses on creating better biologics through innovative technology and partnerships.
- Key Features
Integrated Drug Creation Platform; AI-enabled novel target discovery using Reverse Immunology; Iterative cycles of wet lab and AI for biologics design; Rapid 6-week cycle times for data generation and model training
- Use Cases
Absci's services are most valuable in scenarios involving the development of biologics for complex diseases, particularly in the pharmaceutical industry where rapid and effective drug discovery is critical.
- Competitive advantages
Faster drug creation process with 6-week cycle times; Partnerships with leaders in pharma, tech, and academia; Innovative use of reverse immunology for target discovery
- Strengths
Absci's strengths lie in its advanced technology platform, strong partnerships, and a commitment to accelerating the drug discovery process, which collectively enhance its ability to deliver life-changing medicines.
- Positioning
Absci positions itself as a leader in the drug discovery space, focusing on the integration of AI and synthetic biology to revolutionize the development of biologics.
- Audience
The target users include pharmaceutical companies, biotech firms, and academic institutions looking to innovate in drug discovery and development.
- CTA
Partner with Absci
- Tags
AI Drug Creation
Biologics
Target Discovery
Synthetic Biology
- Tagline
We're unlocking novel biology and creating better biologics with AI
- Tone of Voice
Innovative, collaborative, forward-thinking
- Differentiation
Absci stands out in the market by combining deep learning AI with synthetic biology to create biologics from scratch, significantly reducing the time and cost associated with traditional drug discovery.
- Brand Positioning
Absci's brand identity is centered around innovation, speed, and collaboration, emphasizing its role as a pioneer in biologics development through advanced technology.
- Founded
2011-01-01
- Founders
Sean McClain